# Prevalite

NDC: 0245-0036
Generic name: cholestyramine
Labeler / Manufacturer: Upsher-Smith Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 19960201
Marketing ended: 20271031
FDA application: ANDA073263

## Active ingredients

- CHOLESTYRAMINE: 4 g/5.5g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0245-0036"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0245-0036
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd434ef8-8af3-434c-a0a0-9a0b18459ba0